An increased concentration of cytidine diphosphocholine (CDP-choline) has
been observed in erythrocytes in the hemolytic anemia due to hereditary pyrimidine 5'-
nucleotidase deficiency (P5Nase, EC 3.1.3.5) and in a patient with a chronic hemolytic anemia
not due to P5Nase deficiency, as reported by Paglia and co-workers in 1983. In the
current studies, we were unable to demonstrate a significant inhibitory effect of 4 mmol/l
CDP-choline on the activities of the enzymes of the Embden-Meyerhof and pentose phosphate
pathways. The physiologic significance of increased erythrocytic CDP-choline remains
to be determined.